跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEROPENEM AUROVIT 2.000 MG POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MEROPENEM AUROVIT 2.000 MG POLVO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
MEROPENEM AUROVIT 2.000 MG POLVO PARA SOLUCION PARA PERFUSION
Eugia Pharma (Malta) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 12, 2024
Approval ID
564b69bfad9ca0b5
Company
Eugia Pharma (Malta) Limited
Type
Standard
Approval Details
Approval Id
564b69bfad9ca0b5
Drug Cima Aemps Name
MEROPENEM AUROVIT 2.000 MG POLVO PARA SOLUCION PARA PERFUSION
Register Number
89435
Holder Company Name
Eugia Pharma (Malta) Limited
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2024-03-12
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
2.000 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Eugia Pharma (Malta) Limited
Active Ingredients
MEROPENEM TRIHIDRATO
2.280 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 12, 2024
Approval ID
564b69bfad9ca0b5
Type
Standard
Back to CIMA-AEMPS Approvals